<DOC>
	<DOCNO>NCT01979211</DOCNO>
	<brief_summary>The standard treatment surgery follow radiation therapy stop tumor grow head neck region patient . However , cancer recur spread part body . Cetuximab drug may delay prevent tumor growth block certain cellular chemical pathway lead tumor development . It approve United States Food Drug Administration ( FDA ) 2006 treatment head neck cancer . The purpose study determine easily cetuximab added treatment radiation therapy patient cutaneous cancer head neck . This study also look well cetuximab add radiation therapy work time well treatment tolerate .</brief_summary>
	<brief_title>Post-operative Radiation With Cetuximab Locally Advanced Cutaneous Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description>This Phase II trial characterize feasibility treat patient locally advance cutaneous squamous cell carcinoma head neck post-operative radiotherapy cetuximab . Cetuximab previously give safely conjunction head neck radiotherapy mucosal squamous cell carcinoma multiple phase III trial , Phase I data necessary .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Pathologically ( histologically ) proven diagnosis cutaneous squamous cell carcinoma head neck Clinical stage &gt; /= T3 &gt; /= N1 , M0 include distant metastasis Gross total resection primary tumor curative intent must complete within 7 week registration Performance status 01 within 2 week prior registration Age &gt; /= 18 Adequate lab within 2 week prior registration Prior invasive malignancy unless disease free minimum 3 year ; noninvasive cancer ( For example , carcinoma situ breast , oral cavity , cervix permissible ) permit even diagnose treat &lt; 3 year ago . Patients history T12 , N0 , M0 resect differentiate thyroid carcinoma consider eligible . Prior systemic chemotherapy antiepidermal growth factor therapy study cancer different prior cancer Prior radiotherapy region study cancer would result overlap radiation therapy field</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>head neck cancer</keyword>
</DOC>